Vitamin D for Cardiovascular Disease Prevention in Women: State of the Evidence

[1]  C. Zoccali,et al.  Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end‐stage renal disease (ESRD) patients , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  E. Barrett-Connor,et al.  Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. , 2009, Atherosclerosis.

[3]  J. Eisman,et al.  Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. , 2009, The American journal of medicine.

[4]  R. Thadhani.  Is calcitriol life-protective for patients with chronic kidney disease? , 2009, Journal of the American Society of Nephrology : JASN.

[5]  R. Vasan,et al.  Adiposity, Cardiometabolic Risk, and Vitamin D Status: The Framingham Heart Study , 2009, Diabetes.

[6]  K. Schechtman,et al.  1,25(OH)2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus , 2009, Circulation.

[7]  B. Kestenbaum,et al.  25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. , 2009, Journal of the American Society of Nephrology : JASN.

[8]  C. Zoccali,et al.  Vitamin D levels and patient outcome in chronic kidney disease. , 2009, Kidney international.

[9]  I. Bhan,et al.  Vitamin D therapy for chronic kidney disease. , 2009, Seminars in nephrology.

[10]  J. Manson,et al.  Effect of Calcium and Vitamin D Supplementation on Blood Pressure: The Women's Health Initiative Randomized Trial , 2008, Hypertension.

[11]  A. Reunanen,et al.  Serum Vitamin D and Subsequent Occurrence of Type 2 Diabetes , 2008, Epidemiology.

[12]  B. Astor,et al.  25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.

[13]  E. Yetley.  Assessing the vitamin D status of the US population. , 2008, The American journal of clinical nutrition.

[14]  L. Chaudhary,et al.  Vitamin D receptor activators can protect against vascular calcification. , 2008, Journal of the American Society of Nephrology : JASN.

[15]  B. Kestenbaum,et al.  Association of oral calcitriol with improved survival in nondialyzed CKD. , 2008, Journal of the American Society of Nephrology : JASN.

[16]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[17]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[18]  B. Kestenbaum,et al.  Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women ’ s Health Initiative , 2008 .

[19]  M. Holick,et al.  Vitamin D and Skin Physiology: A D‐Lightful Story , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  N. Bodyak,et al.  Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals , 2007, Proceedings of the National Academy of Sciences.

[21]  Wei Zheng,et al.  1,25-Dihydroxyvitamin D3 Suppresses Renin Gene Transcription by Blocking the Activity of the Cyclic AMP Response Element in the Renin Gene Promoter* , 2007, Journal of Biological Chemistry.

[22]  M. Wolf,et al.  Vitamin D levels and early mortality among incident hemodialysis patients. , 2007, Kidney international.

[23]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[24]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[25]  C. Mathieu,et al.  Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. , 2007, Diabetes research and clinical practice.

[26]  J. Manson,et al.  Calcium/Vitamin D Supplementation and Cardiovascular Events , 2007, Circulation.

[27]  R. Blumenthal,et al.  Vitamin D supplementation and cardiovascular disease risk. , 2007, Circulation.

[28]  L. Carbone,et al.  Micronutrients in African-Americans with decompensated and compensated heart failure. , 2006, Translational research : the journal of laboratory and clinical medicine.

[29]  M. Nicholls,et al.  Hypothesis: Correction of low vitamin D status among Arab women will prevent heart failure and improve cardiac function in established heart failure , 2006, European journal of heart failure.

[30]  G. Targher,et al.  Serum 25‐hydroxyvitamin D3 concentrations and carotid artery intima‐media thickness among type 2 diabetic patients , 2006, Clinical endocrinology.

[31]  L. Carbone,et al.  Secondary Hyperparathyroidism and Hypovitaminosis D in African-Americans with Decompensated Heart Failure , 2006, The American journal of the medical sciences.

[32]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[33]  Hyung Wook Kim,et al.  Calcitriol Regresses Cardiac Hypertrophy and QT Dispersion in Secondary Hyperparathyroidism on Hemodialysis , 2005, Nephron Clinical Practice.

[34]  M. Hernán,et al.  Activated injectable vitamin D and hemodialysis survival: a historical cohort study. , 2005, Journal of the American Society of Nephrology : JASN.

[35]  M. Wolf,et al.  Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. , 2003, The New England journal of medicine.

[36]  G. Tenderich,et al.  Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? , 2003, Journal of the American College of Cardiology.

[37]  R. Wood,et al.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line , 2001, BMC Physiology.

[38]  H. Minne,et al.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.

[39]  C. Park,et al.  Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  Barrett T. Kitch,et al.  Hypovitaminosis D in medical inpatients. , 1998, The New England journal of medicine.

[41]  K. Watson,et al.  Active serum vitamin D levels are inversely correlated with coronary calcification. , 1997, Circulation.

[42]  D. Mancini,et al.  Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. , 1997, The American journal of medicine.

[43]  R. Beaglehole,et al.  Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. , 1990, International journal of epidemiology.

[44]  R. Simpson,et al.  Vitamin D3 and cardiovascular function in rats. , 1987, The Journal of clinical investigation.

[45]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.